Author(s): Pandiyan P, Zhu J
CD4+CD25+Foxp3+ regulatory cells (Tregs) are a special lineage of cells central in the maintenance of immune homeostasis, and are targeted for human immunotherapy. They are conventionally associated with the production of classical anti-inflammatory cytokines such as IL-10, TGF-β and IL-35, consistent to their anti-inflammatory functions. However, emerging evidence show that they also express effector cytokines such as IFN-γ and IL-17A under inflammatory conditions. While some studies reveal that these pro-inflammatory cytokine producing Foxp3+ regulatory cells retain their suppressive ability, others believe that these cells are dys-regulated and are associated with perpetuation of immunopathology. Therefore the development of these cells may challenge the efficacy of human Treg therapy. Mechanistically, toll-like receptor (TLR) ligands and the pro-inflammatory cytokine milieu have been shown to play important roles in the induction of effector cytokines in Tregs. Here we review the mechanisms of development and the possible functions of pro-inflammatory cytokine producing Foxp3+ Tregs.
Author(s): Girolomoni G, Mrowietz U, Paul C
Author(s): Gorouhi F, Davari P, Fazel N
Author(s): Robinson KM, Manni ML, Biswas PS, Alcorn JF
Author(s): Berg RE, Forman J
Author(s): De Vries HJ, Van Marle J, Teunissen MB, Picavet D, Zorgdrager F, et al.
Author(s): Shen Z, Gao X, Ma L, Zhou Z, Shen X, et al.